Study design: Prospective health economic evaluation
Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma
Article first published online: 12 NOV 2008
© 2008 The Authors. Journal compilation © 2008 Blackwell Munksgaard
Volume 63, Issue 12, pages 1624–1629, December 2008
How to Cite
Nasser, S., Vestenbæk, U., Beriot-Mathiot, A. and Poulsen, P. B. (2008), Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma. Allergy, 63: 1624–1629. doi: 10.1111/j.1398-9995.2008.01743.x
- Issue published online: 12 NOV 2008
- Article first published online: 12 NOV 2008
- Accepted for publication 6 March 2008
- 7Asthma UK. Where do we stand? Asthma in the UK today. http://www.asthma.org.uk/document.rm?id=92.
- 9BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008;38:19–42., , , , , et al.
- 14Methods for the economic evaluation of health care programmes, 3rd edn. Oxford: Oxford Medical Publications, Oxford University Press, 2005., , , , .
- 15EFA (European Federation of Allergy and Airway Diseases Patients Association). Results of the patient voice allergy survey. Impact of allergic rhinitis in Europe. Summary Report (2005) ( http://www.efanet.org/ ).
- 16Unit Costs of Health and Social Care 2004, Personal Social Services Research Unit, University of Kent, Canterbury. http://www.pssru.ac.uk/pdf/uc2004/uc2004.pdf ., .
- 17Department of Health. NHS reference costs 2004. http://www.dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/DH_4105545?Idcservice-GET_FILE&dID=19536&Reudition-Web.
- 22NHS. National Institute of Clinical Excellence. Guide to the Methods of Technology Appraisal. April, 2004. http://www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf